Similar companies
Income Statement (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Revenue | 107M | 11.6% |
| Gross Profit | 91M | 15.1% |
| Cost of Revenue | 15M | 5% |
| Operating expense | 72M | 7.5% |
| Net Income | -207M | 769.7% |
| EBITDA | -202M | 1441.9% |
Balance Sheet (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Total Assets | 629M | 13.1% |
| Total Liabilities | 331M | 44.5% |
| Total Equity | 298M | 842.8% |
| Shares Outstanding | 209M | 4.9% |
Cash Flow (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Cash from operations | 42M | 187% |
| Cash from financing | 5.5M | 66.3% |
EPS
Financial Highlights for Cellebrite DI in Q2 '24
Cellebrite DI reported a revenue of 107M, which is a 11.6% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 91M, marking a 15.1% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 15M, a -5% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 72M, showing a 7.5% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -207M, showing a -769.7% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -202M, showing a -1441.9% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Cellebrite DI faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.
